Menu Search
Equities

Hemogenyx Pharmaceuticals PLC

HEMO:LSE

Hemogenyx Pharmaceuticals PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (GBX)1.56
  • Today's Change0.031 / 2.01%
  • Shares traded25.04m
  • 1 Year change-37.78%
  • Beta3.9331
Data delayed at least 20 minutes, as of Nov 22 2024 11:52 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in GBPView more

In 2023, cash reserves at Hemogenyx Pharmaceuticals PLC fell by 1.29m. Cash Flow from Financing totalled 4.45m or -- of revenues. In addition the company used 6.11m for operations while cash used for investing totalled 31.94k.
Cash flow per share-0.0037
Price/Cash flow per share--
Book value per share0.0023
Tangible book value per share0.0019
More ▼

Balance sheet in GBPView more

Hemogenyx Pharmaceuticals PLC has a Debt to Total Capital ratio of 47.94%, a lower figure than the previous year's 76.88%.
Current ratio4.38
Quick ratio--
Total debt/total equity0.9087
Total debt/total capital0.4794
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.